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Mounting evidence suggests that stem/progenitor cellsmay be the cells of origin formany tumor types. In this
issue of Cell Stem Cell, Le et al. (2009) demonstrate that skin-derived precursors (SKPs) can initiate dermal
neurofibromas and highlight the importance of the microenvironment in the formation of this complex tumor.Tumorigenesis is an enigmatic process
whereby certain cells acquire the capacity
to evade the molecular measures that
normally control cell proliferation and
survival. The study of familial tumor
syndromes (FTSs), such as neurofibroma-
tosis type 1 (NF1), has afforded unique
insight into the genetic basis of neoplasia
and advanced our understanding of these
molecular controls. FTS patients typically
carry a constitutional heterozygous muta-
tion of a specific tumor suppressor gene
and develop characteristic distributions
of primary tumors throughout their life-
times as a result of recurring somatic inac-
tivation of the remaining wild-type allele.
Although FTS patients are predisposed
to a unique and restricted spectrum of
tumors,FTS-associated tumorsuppressor
genes are often widely expressed, sug-
gesting that certain ‘‘cells of origin’’ are
particularly sensitive to loss of a specific
tumor suppressor. The identification and
study of the cells that initiate individual
tumor types is critical to understanding
this apparent sensitivity. In the current
issue of Cell Stem Cell, Le et al. make an
important contribution to this effort and
identifyskin-derivedneuralprogenitorcells
(SKPs) as a putative cell of origin for dermal
neurofibromas in NF1 (Le et al., 2009).
NF1 is the most common FTS, affecting
1 in 3500 people globally and resulting
frommutationof theNF1 tumor suppressor
gene, which encodes a GTPase-activating
protein (GAP) that negatively regulates the
Ras oncoprotein (Rubin and Gutmann,
2005). The hallmark of NF1 is the develop-
ment of multiple neurofibromas. These
complex tumors are composed of hyper-
proliferating Schwann cells that exhibit
biallelicNF1 loss as well as non-neoplastic
cells that may be critical to tumorigenesis
including neurons, perineurial cells, fibro-blasts, mast cells, and endothelial cells
(Zhu et al., 2002). Neurofibromas are clas-
sified as dermal, subcutaneous, or plexi-
form, and their shared histological features
suggest a common cell- of-origin. Yet, the
neurofibromasubtypesexhibit uniquespa-
tiotemporal characteristics. Thus, plexi-
form tumors are frequently congenital and
enlarge along deep nerve plexi throughout
a patient’s lifetime, whereas dermal and
subcutaneous tumors originate near the
skin surface and increase in incidence and
size during periods of hormone elevation
such as puberty or pregnancy (Roth et al.,
2008). These differences suggest that des-
pite their histological similarities, plexiform,
subcutaneous, and dermal neurofibromas
may, in fact,arise fromdistinctcellsoforigin.
Investigatorsdevelopingmousemodels
of NF1-associated tumorigenesis have
pioneered efforts to use genetically engi-
neered mice (GEM) to study tumor initia-
tion. Although Nf1+/ mice succumb to
various malignancies during late adult-
hood without developing neurofibromas
(Jacks et al., 1994), chimeric mice that
are partly composed of Nf1/ cells
do develop plexiform neurofibromas
(Cichowski et al., 1999). This observation
indicated that loss of the wild-type Nf1
allele is rate-limiting for neurofibroma
development, perhaps because the target
cell (the cell of origin) population is small
or transient. Later studies revealed that
conditional inactivation ofNf1 in Schwann
cell progenitors using eitherKrox20-Creor
P0A-Cre transgenes results in plexiform
neurofibroma formation, although the
anatomical distribution of tumors elicited
by each transgene was distinct (Zheng
et al., 2008; Zhu et al., 2002). The first
hint that a heterozygous microenviron-
ment is critical for plexiform neurofibroma
development came from the observationCell Stemthat tumors do arise in Krox20-Cre;Nf1lox/-
mice, but not in Krox20-Cre;Nf1lox/loxmice
(Zhu et al., 2002). Additional studies
revealed that Nf1/ neural crest stem
cells do not give rise to neurofibromas of
any subtype, implicating later, more
restricted progenitors or Schwann cells
themselves as the neurofibroma cell of
origin (Joseph et al., 2008). Indeed, it
has been proposed that Nf1 loss must
occur in a post-neural-crest Schwann
cell progenitor, but that neurofibromas
themselves arise later from the mature
nonmyelinating Schwann cell progeny of
the more primitive, mutated initiating cell
(Zheng et al., 2008). Notably, dermal
neurofibromas did not develop efficiently
in any of these models, suggesting that
the cell of origin for these tumors is distinct
from the population that gives rise to plex-
iform neurofibromas.
With this potential difference in tumor
origins in mind, Le et al. used two
approaches to ask whether dermal neuro-
fibromas arise from a neural-crest-like
adult progenitor known as a skin-derived
neural precursor cell (SKP) (Fernandes
et al., 2008). Although a SKP population
has not yet been identified in vivo, SKPs
have been defined in vitro as nonadherent
cells isolated from the dermis that prolif-
erate and self-renew in response to FGF-2
and EGF stimulation and that can differen-
tiate into both neuronal and glial lineages
(Fernandes et al., 2008). In the first
approach, Le et al. isolated Nf1lox/- SKPs,
induced Cre-mediated recombination
in vitro, and transplanted them subcuta-
neously back into the same Nf1lox/- host
(Figure 1A). They found that Nf1/ SKPs
could initiate dermal neurofibromas, but
tumor formation was only efficient in
female Nf1lox/- recipients that were preg-
nant at the time of implantation,Cell 4, May 8, 2009 ª2009 Elsevier Inc. 371
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PreviewsFigure 1. The Influence of
Microenvironment on SKP-Initiated
Neurofibroma Formation in Nf1lox/ Mice
(A) Transplantation studies suggest that SKPs can
initiate dermal neurofibromas under certain condi-
tions. (Top) Autologous transplantation of Nf1/
SKPs into the skin of male or nonpregnant female
Nf1lox/ mice does not efficiently yield dermal
neurofibromas, perhaps because they fail to
readily encounter the peripheral nerve endings,
which may represent the ideal microenvironment.
However, transplantation of Nf1/ SKPs into
pregnant Nf1lox/ mice yields multiple dermal
neurofibromas within 3 to 4 months (middle). The
microenvironment (green) is altered by hormonal
changes and likely contributes to the tumor-form-
ing capacity of the transplanted SKPs. (Bottom)
Transplantation of Nf1/ SKPs onto the large
sciatic nerve led to plexiform neurofibroma forma-
tion regardless of hormonal influence, strongly
indicating that the peripheral nerve microenviron-372 Cell Stem Cell 4, May 8, 2009 ª2009 Elsrecapitulating the hormone sensitivity ob-
served inNF1patients andhighlighting the
importance of the microenvironment
during neurofibroma formation. In fact,
ectopically implanted Nf1/ SKPs are
the first cell type to recapitulate the com-
plex histology of human neurofibromas.
In the second approach, Le et al. showed
that deletion of Nf1 in the skin of CMV-
CreERT2;Nf1lox/- mice after topical appli-
cation of tamoxifen led to local dermal
neurofibroma formation, supporting the
notion that the cell of origin for these
tumors resides in the skin (Figure 1B).
This work from the Parada laboratory
provides strong evidence that SKPs can
be a cell of origin for dermal neurofi-
bromas. However, a determination of the
physiological importance of these cells
awaits their definitive identification in vivo.
Indeed, due to the lack of an avail-
able SKP-specific promoter, the authors
are unable to definitively demonstrate
that endogenous SKPs do give rise to
dermal neurofibromas or to rule out the
possibility that other cells can do the
same. Notably, the authors also demon-
strate that Nf1/ SKPs can form plexi-
form neurofibromas when ectopically
positioned along the sciatic nerve of
Nf1lox/- mice, despite the fact that SKPs
are not thought to normally be present in
this location (Figure 1A). This finding sug-
gests that the dermal microenvironment
does not completely define the neurofi-
broma-forming potential of SKPs and
hints that there may be some plasticity
associated with the neurofibroma cell of
origin. In fact, it has been reported that
both plexiform and dermal neurofibromas
develop in Dhh-Cre;Nf1lox/lox mice, which
express Cre in the post-neural-crest glial
lineage and in other cell types (Wu et al.,
2008). This could reflect the inactivation
ment has an important positive influence on neuro-
fibroma formation.
(B) Acute deletion of Nf1 throughout the skin via
topical application of tamoxifen to CMV-CreERT2;
Nf1lox/ skin gives rise to dermal neurofibromas. In
this case, the cell of origin is targeted in situ, where
the natural microenvironment likely plays a promi-
nent role in tumor formation. SKPs are a candidate
cell of origin, but this population has not yet been
identified in vivo.
(C) Neurofibroma formation in human NF1 patients
involves somatic inactivation of NF1 in a single cell
of origin in the context of a NF1 heterozygous
mutant microenvironment. None of the existing
mouse models precisely recapitulate this physio-
logic scenario in which the role of the microenvi-
ronment and the sensitivity of putative cells of
origin to NF1 loss may be unique.evier Inc.of Nf1 in two distinct cell lineages and/or
the possibility that the cells of origin for
dermal and plexiform neurofibromas
derive from a common progenitor.
Clearly, additional work will be neces-
sary to establish a unified view of the
neurofibroma cell of origin, particularly
given the intricate functional compart-
mentalization of the Schwann cell lineage.
Any model must take into account the
physiological setting of neurofibroma initi-
ation. In an NF1 patient, loss of the wild-
type NF1 allele almost certainly occurs
in a single cell that is surrounded by a
NF1+/ microenvironment (Figure 1C). In
this setting, which is not truly recapitu-
lated by any of the existing mouse
models, the interface between that cell
and its microenvironment may be para-
mount, and the sensitivity of a particular
cell to becoming a neurofibroma-initiating
cell may be quite different. By simple anal-
ogy, on the baseball field, a sharply hit
single has much greater impact when the
bases are loaded rather than empty. This
paradigm applies to any type of cancer,
of course, but it seems likely that the
development and study of NF1 GEM
models will continue to lead the way in
delineating the process of tumor initiation.
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